Michael Novogratz’s Fortress Investment Trims Stake in Cardiome Pharma (CRME)

A recent 13G filing shows that Michael Novogratz’s Fortress Investment Group trimmed its passive stake in Cardiome Pharma Corp. (NASDAQ:CRME) to 981,600 shares from 2.5 million shares held previously. Fortress Investment currently holds 6.5% of the company’s common stock.

top hedge funds

In November 2013, Fortress initiated position in Cardiome, disclosing ownership of 2.5 million shares, equal to almost 17% of the stock. Since the position has been revealed the stock has gained over 40%.

Cardiome Pharma Corp. (NASDAQ:CRME) is an integrated, commercial, specialty pharmaceutical company, based in Canada. Earlier this week, in a press release, Cardiome Pharma Corp. (NASDAQ: CRME) and CarCor Investment Holdings LLC announced the closing of their previously announced prospectus offering of 1.5 million common shares for gross proceeds of $13.5 million and 1.5 million shares in a secondary offering from CarCor for gross proceeds of $13.5 million both at roughly $9 per common share, for a combined offering of approximately $27.0 million. The company intends to use the net proceeds of the primary offering for working capital and general corporate purposes, including to fund expansions in Europe and other parts of the world.

Cardiome and CarCor have granted the underwriters an over-allotment option to purchase, pro rata from each of Cardiome and CarCor, up to an additional 15% or an aggregate of up to 450,000 common shares of the offering on the same terms and conditions, exercisable in whole or in part at any time for a period of 30 days following closing of the offering.

Analysts at Canaccord Genuity upgraded shares of Cardiome Pharma Corp (NASDAQ:CRME) to a buy rating from its previous hold rating. R.F Lafferty started coverage on the stock with a ‘buy’ recommendation with a target price of $9 per share.

Other significant stakeholders of Cardiome Pharma Corp include Phill Gross and Robert’s Atchinson’s Adage Capital Management, which holds 1.3 million shares, followed by Casey Nelson’s Alistair Capital, with ownership of 917,000 shares. Next up is Renaissance Technologies, led by billionaire Jim Simons, which owns approximately 218,900 shares of the pharma company.

Fortress Investment Group began as a private equity firm in 1998. It was founded by Wesley R. Edens, a former partner at BlackRock Financial; Robert Kauffman, a managing director at UBS; and Randal A. Nardone, also a managing director at UBS. Princeton graduates Michael Novogratz and Pete Briger, both former partners at Goldman Sachs, were brought in four years later to run Fortress Investment’s hedge funds as well as its new real estate-related investments and debt securities. The fund is heavily weighted towards the financial and healthcare sectors. It had $6.5 billion in its equity portfolio at the end of last year.

Last month, Fortress Investment upped its position in Brookdale Senior Living Inc. (NYSE:BKD) to 20.3 million shares from 17.6 million held earlier. The new position amounts to 16.3% of the company’s common stock.

Some of the largest investments of the fund as at the end of the fourth quarter of 2013 include Nationalstar Manufacturing Holdings Inc (NYSE:NSM) in which Fortress owns approximately 67.8 million shares worth $2.5 billion. The fund also holds 73.4 million shares of Springleaf Holdings Inc. (NYSE:LEAF) with a reported value of $1.9 billion.

Disclosure:none

Recommended Reading:

Cadence Pharmaceuticals, Inc. (CADX), Griffin Land & Nurseries, Inc. (GRIF) and Three Other Moves From Mario Gabelli and GAMCO Investors

Odey Asset Management Reduces Position in LSE-listed STV Group Plc. (STVG)

Ardsley Partners Trims Stake to 6.8% in World Energy Solutions (XWES)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!